Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma

Conditions:   Oral Cancer;   VEGFR2 Inhibitor;   Programmed Cell Death 1 Inhibitor;   Inductive Therapy Interventions:   Drug: Camrelizumab;   Drug: Apatinib;   Procedure: Radical surgery;   Radiation: Post-operative radiotherapy/chemoradiotherapy Sponsor:   Shanghai Jiao Tong University School of Medicine Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials